ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Water → 1-[3-(4-Chloro-phenyl)-[1,2,4]thiadiazol-5-yl]-4-[2-(4-methoxy-phenyl)-allyl]-piperazine

HRID 570569
印刷

反応式

HRID 570569 の反応式
[Br-].[CH3:2][P+](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.[NH2-].[Na+].[Cl:24][C:25]1[CH:30]=[CH:29][C:28]([C:31]2[N:35]=[C:34]([N:36]3[CH2:41][CH2:40][N:39]([CH2:42][C:43]([C:45]4[CH:50]=[CH:49][C:48]([O:51][CH3:52])=[CH:47][CH:46]=4)=O)[CH2:38][CH2:37]3)[S:33][N:32]=2)=[CH:27][CH:26]=1.O.CCOC(C)=O>C1COCC1>[Cl:24][C:25]1[CH:26]=[CH:27][C:28]([C:31]2[N:35]=[C:34]([N:36]3[CH2:41][CH2:40][N:39]([CH2:42][C:43]([C:45]4[CH:46]=[CH:47][C:48]([O:51][CH3:52])=[CH:49][CH:50]=4)=[CH2:2])[CH2:38][CH2:37]3)[S:33][N:32]=2)=[CH:29][CH:30]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 962WaterHCID 8857Ethyl AcetateHCID 16212304Sodium;azanide;methyl(triphenyl)phosphanium;bromideHCID 711862252-(4-(3-(4-Chlorophenyl)-1,2,4-thiadiazol-5-yl)piperazin-1-yl)-1-(4-methoxyphenyl)ethanone

生成物 1

HCID 715033301-[3-(4-Chloro-phenyl)-[1,2,4]thiadiazol-5-yl]-4-[2-(4-methoxy-phenyl)-allyl]-piperazine

試薬・触媒・溶媒 1

HCID 8028Tetrahydrofuran溶媒2 回

実験手順

A mixture of methyltriphenylphosphonium bromide/sodium amide (57.7 mg, 146 μmol) was combined with THF (5 mL) to give a yellow suspension and stirred for 1 h at RT. 2-(4-(3-(4-chlorophenyl)-1,2,4-thiadiazol-5-yl)piperazin-1-yl)-1-(4-methoxyphenyl)ethanone (50 mg, 117 μmol) dissolved in THF (3 mL) was added drop-wise via syringe over 5 min. The resulting orange suspension was stirred over night at RT. Water (10 mL) and EtOAc (10 mL) was added and stirred for 10 min. The aqueous layer was separated and extracted with EtOAc (1×10 mL). The organic layers were washed with brine (1×10 mL), dried over Na2SO4, filtered off and concentrated in vacuo. The residue was purified by column chromatography on silica eluting with a gradient formed from heptane and EtOAc to yield, after evaporation of the product containing fraction, 33 mg (66%) of the title compound as off-white solid. MS (m/e): 427.2 (MH+).

後処理

  1. customto give a yellow suspension
  2. additionwas added drop-wise via syringe over 5 min
  3. stirringThe resulting orange suspension was stirred over night at RT
  4. stirringstirred for 10 min
  5. customThe aqueous layer was separated
  6. extractionextracted with EtOAc (1×10 mL)
  7. washThe organic layers were washed with brine (1×10 mL)
  8. dry with materialdried over Na2SO4
  9. filtrationfiltered off
  10. concentrationconcentrated in vacuo
  11. customThe residue was purified by column chromatography on silica eluting with a gradient
  12. customformed from heptane and EtOAc
  13. customto yield
  14. customafter evaporation of the product
  15. additioncontaining fraction, 33 mg (66%) of the title compound as off-white solid

出典と根拠

ORDレコード
ord-b37171b11e6b4a79a9c0c57e6227a791
出典データセット
uspto-grants-2015_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09023852B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート